EarningsNovo Nordisk Crushes Q1 Forecasts—But Slashes 2025 Outlook Anyway Despite record-breaking Q1 earnings from Wegovy and Ozempic sales, Novo Nordisk mysteriously slashes its 2025 outlook. What’s really going on?Richard's Trades TeamMay 8, 2025
EarningsPalantir Surges, Crushes Earnings—Then Craters: What Spooked Investors? Despite crushing earnings and 340% returns, Palantir’s stock nosedived 20% in a puzzling market reaction. What made investors run scared?Richard's Trades TeamMay 7, 2025
EarningsWhy Super Micro’s Surprising Earnings Forecast Could Leave Unity and Altera Investors Reeling Super Micro’s brutal $1.4B revenue cut sends shockwaves through tech stocks. Will Unity and Altera investors survive this market-rattling blow?Richard's Trades TeamMay 5, 2025
EarningsWhy Coca-Cola’s Earnings Reveal More Than Just Profits This Quarter Beyond profits and margins, Coca-Cola’s earnings mask a stunning global shift. Market powers are changing in ways nobody saw coming.Richard's Trades TeamApril 29, 2025
EarningsWhy Jamie Dimon Thinks S&P 500 Earnings Are About to Disappoint Investors Wall Street’s optimistic earnings predictions clash with Jamie Dimon’s grim warning of a potential 5% drop. Market forces are telling a different story.Richard's Trades TeamApril 15, 2025